CSL - Dividend History | CSLLY

Historical dividend payout and yield for CSL (CSLLY) since 1971. The current TTM dividend payout for CSL (CSLLY) as of December 31, 1969 is $1.09. The current dividend yield for CSL as of December 31, 1969 is 1.17%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $90.339B $13.310B
CSL Ltd. is a biopharmaceutical company. It engages in researches, develops, manufactures and markets vaccines and plasma protein biotherapies to treat and prevent human medical conditions. The company's operating segments consists of CSL Behring and bioCSL. CSL Behring segment provides plasma-derived and recombinant products, and operates plasma collection networks through CSL Plasma. bioCSL segment manufactures, sells and distributes vaccines, antivenoms and other pharmaceutical products primarily in Australia and New Zealand; as well as also manufactures and markets in vitro diagnostic products through Immunohaematology. It operates primarily in Germany, Switzerland and the United States. CSL Ltd. is headquartered in Parkville, Australia.
Stock Name Country Market Cap PE Ratio